Wed, Sep 18, 2024
Biocon has announced that LIC has increased its shareholding in their equity shares to 5.023 per cent.
More >
Thu, Apr 18, 2024
Under the terms of this agreement, Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market, the company said in a statement on Wednesday.
Thu, Feb 08, 2024
EBITDA, or earnings before interest, taxes, depreciation, and amortisation, is also set to log a double-digit increase of 29 per cent in Q3 to Rs 830 crore as against Rs 646 crore logged in Q3 FY23.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
